Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Rohde

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Electronic Markets|October 31, 2022
Explaining reviewing effort: Existing reviews as potential driverChristoph Rohde, Alexander Kupfer, Steffen Zimmermann
Japanese Journal of Clinical Oncology|May 16, 2019
Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinomaChristoph Rohde, Rin Yamaguchi, Svetlana Mukhina, et al.
Gene|May 17, 2011
Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammalsOzlem Türeci, Michael Koslowski, Gerd Helftenbein, et al.
Memorias Do Instituto Oswaldo Cruz|May 12, 2009
Toxoplasma gondii and the Immunity-Related GTPase (IRG) resistance system in mice: a reviewYang Oliver Zhao, Christoph Rohde, Jing Tao Lilue, et al.
Genome Biology|November 10, 2005
The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineageCemalettin Bekpen, Julia P Hunn, Christoph Rohde, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2018
A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancerUgur Sahin, Martin Schuler, Heike Richly, et al.
Oncotarget|June 6, 2020
PLAC1 is essential for FGF7/FGFRIIIb-induced Akt-mediated cancer cell proliferationDiana Barea Roldán, Matthias Grimmler, Christoph Hartmann, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Electronic Markets|October 31, 2022
Explaining reviewing effort: Existing reviews as potential driverChristoph Rohde, Alexander Kupfer, Steffen Zimmermann
Japanese Journal of Clinical Oncology|May 16, 2019
Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinomaChristoph Rohde, Rin Yamaguchi, Svetlana Mukhina, et al.
Gene|May 17, 2011
Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammalsOzlem Türeci, Michael Koslowski, Gerd Helftenbein, et al.
Memorias Do Instituto Oswaldo Cruz|May 12, 2009
Toxoplasma gondii and the Immunity-Related GTPase (IRG) resistance system in mice: a reviewYang Oliver Zhao, Christoph Rohde, Jing Tao Lilue, et al.
Genome Biology|November 10, 2005
The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineageCemalettin Bekpen, Julia P Hunn, Christoph Rohde, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2018
A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancerUgur Sahin, Martin Schuler, Heike Richly, et al.
Oncotarget|June 6, 2020
PLAC1 is essential for FGF7/FGFRIIIb-induced Akt-mediated cancer cell proliferationDiana Barea Roldán, Matthias Grimmler, Christoph Hartmann, et al.
Pageof 1